# Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia with Daridorexant in Canada

> **NCT06311864** · — · ENROLLING_BY_INVITATION · sponsor: **PeriPharm** · enrollment: 100 (estimated)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Daridorexant 50 mg

## Key facts

- **NCT ID:** NCT06311864
- **Lead sponsor:** PeriPharm
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-06-20
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06311864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06311864, "Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia with Daridorexant in Canada". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06311864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*